Research & Development

At Stallergenes Greer we aim to enable people with allergies to live normal lives. To do that we’re changing the treatment paradigm of allergy therapies by delivering curative medicines and innovative tools. Central to our progress is our research and pipeline, bringing to market our next-generation products and technologies. Our pipeline today covers main respiratory allergens and we are primed to expand further.

Each year, approximately 1.6 million patients are treated with Stallergenes Greer medicines. Stallergenes Greer is firmly focused on innovation, and thanks to unique expertise in its knowledge of allergens, the Company makes a major contribution to the development of allergy immunotherapy, offering allergy sufferers a comprehensive range of increasingly...